News · Longevity & Aging
Preventive womb removal cost quality of life only in women who had not reached menopause
Surgery to prevent cancer in women at high inherited risk is offered on the assumption that the trade is worth it. Comparing 1,120 women found the cost concentrated entirely in one group.
- Overall quality of life barely differed between women who had the surgery and those who had not.
- Premenopausal women who had it scored measurably lower.
- Postmenopausal women showed no difference at all.
- Worry about cancer was low in both groups.
- A snapshot comparison, and the two groups differed in age by sixteen years.
Risk-reducing surgery asks a woman to accept a certain, immediate loss in exchange for a probable, distant gain. The cancer that never arrives is invisible; the operation and everything that follows it are not.
For women carrying a high inherited risk of cancer of the womb lining, removing the uterus before anything grows in it is the most effective prevention available. What that costs the woman afterwards has been assumed more than measured.
Writing in EClinicalMedicine, researchers measured it. Analysis included 1120 participants, of whom 529 had undergone the surgery. Previously the quality-of-life cost had been assumed rather than quantified, and never split by menopausal status.
The overall answer, which is nearly nothing
Adjusted quality-of-life scores were slightly lower in the surgery group, by about two hundredths of a point on a scale where one is full health.
The range around that difference crosses zero. Taken at face value it says the operation costs little or nothing in how women rate their health afterwards.
That is a reassuring headline and it turns out to be an average concealing two very different groups.
Where the cost actually falls
Split by menopausal status and the picture separates cleanly.
Premenopausal women who had the surgery scored about four hundredths lower, roughly double the overall figure and with a range that stays clear of zero.
Postmenopausal women showed a difference of three thousandths, which is indistinguishable from nothing.
So the operation is close to free in quality-of-life terms for women who have been through menopause, and carries a measurable cost for those who have not.
Why that split makes sense
For a postmenopausal woman, a hysterectomy removes an organ whose functions have already ended. Fertility is gone, periods have stopped, and the hormonal consequences that matter come from ovaries rather than uterus.
For a premenopausal woman the same operation ends the possibility of carrying a pregnancy, and where the ovaries are removed alongside it produces menopause in a single afternoon, decades early, with the hot flushes, bone loss and cardiovascular consequences that follow.
Same procedure, different meaning, and the numbers detect the difference.
What the study is not measuring
This is the part most likely to be misread. Quality of life is one side of the ledger.
The other side is cancer, and it is entirely absent from these numbers. A hysterectomy is surgery to remove the uterus, and in this population it prevents a cancer that would otherwise arrive in a meaningful fraction of women. Nothing in a quality-of-life comparison captures a cancer that did not happen.
A finding that the surgery costs four hundredths of a utility point in premenopausal women is not an argument against it. It is a quantity to put on one side of a decision whose other side is measured in cancers and deaths.
The design’s limitations
The two groups were sixteen years apart in median age, 55 against 39, and the surgery group was more likely to have had cancer and to carry other physical illness. The comparison is adjusted, and adjustment does not make two such different groups equivalent.
Everyone was surveyed once, so this cannot say whether the premenopausal difference fades as women move through the years after surgery. It may be the acute cost of a recent operation rather than a permanent state.
Cancer worry was low in both groups, which is worth noting for two reasons: it argues against the operation working mainly by relieving dread, and it removes anxiety as an explanation for the difference that was found.
What it is useful for
Counseling. A woman weighing this surgery is entitled to a number rather than reassurance, and the useful version of that number is the one for her situation rather than the average of everyone’s.
For a woman past menopause, this study says the quality-of-life cost is close to zero. For a woman before it, the cost is real, small, and worth naming out loud in the conversation where she decides.
People also ask
What did the study find?
Adjusted mean utilities were slightly lower in the risk-reducing hysterectomy group than the no-surgery group (difference -0.020; 95% CI -0.045 to 0.004; p = 0.11), much lower for premenopausal women (-0.041; -0.074 to -0.008), but similar for postmenopausal women (0.003; -0.036 to 0.042). Cancer Worry Scale scores were low.
Who has this surgery?
Women at high inherited risk of cancer of the womb lining, most often through Lynch syndrome, a genetic condition that also raises bowel cancer risk. Removing the uterus removes the organ the cancer would arise in.
What is a utility score?
A single number summarising health-related quality of life on a scale where 1 is full health. Differences of a few hundredths are small individually and are the currency health systems use to compare interventions.
Why would premenopausal women fare differently?
Because for them the surgery ends fertility and, where ovaries are also removed, triggers abrupt menopause. A postmenopausal woman has already passed both of those, so the operation removes an organ whose functions she was no longer using.
Does this mean the surgery is not worth it?
No. It measures quality of life, not cancer prevented or deaths avoided, and the whole point of the operation is the cancers that never happen. This describes one side of a trade.
What does the low cancer worry tell us?
That worry was not high in either group, which cuts against the idea that the surgery mainly works by relieving anxiety. It also means anxiety relief cannot explain away the difference found.
How should a woman weigh this?
With a genetics service and a gynecologist, factoring in her own risk, whether she has completed her family, and her menopausal status. This is general information rather than medical advice.